Topical podophyllum-induced toxic anterior uveitis. 2011

Kavitha Avadhani, and Padmamalini Mahendradas, and Rohit Shetty, and Bhujang K Shetty
Uveitis and Ocular Immunology Services, Narayana Nethralaya, Bangalore, India. kavithaviswa@gmail.com

OBJECTIVE To report a case of toxic anterior uveitis probably secondary to the use of topical podophyllum. METHODS Case report, interventional. METHODS The authors present a 78-year-old male with acute anterior uveitis that developed within a couple of hours of application of topical podophyllum. In vivo confocal microscopy showed unique findings that disappeared following treatment with topical steroids alone. The patient reapplied podophyllum 2 months later and a recurrence of uveitis was noted. RESULTS A score of 7 was obtained using the adverse drug reaction probability scale, suggesting that the anterior uveitis is a probable adverse reaction to topical podophyllum. CONCLUSIONS Anterior uveitis may occur after topical application of podophyllum.

UI MeSH Term Description Entries
D008297 Male Males
D008517 Phytotherapy Use of plants or herbs to treat diseases or to alleviate pain. Herb Therapy,Herbal Therapy
D009184 Mydriatics Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. Cycloplegic,Cycloplegics,Mydriatic,Mydriatic Effect,Mydriatic Effects,Effect, Mydriatic,Effects, Mydriatic
D011035 Podophyllum A genus of poisonous American herbs, family BERBERIDACEAE. The roots yield PODOPHYLLOTOXIN and other pharmacologically important agents. The plant was formerly used as a cholagogue and cathartic. It is different from the European mandrake, MANDRAGORA. Podophyllums
D005145 Face The anterior portion of the head that includes the skin, muscles, and structures of the forehead, eyes, nose, mouth, cheeks, and jaw. Faces
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012871 Skin Diseases Diseases involving the DERMIS or EPIDERMIS. Dermatoses,Skin and Subcutaneous Tissue Disorders,Dermatosis,Skin Disease
D013256 Steroids A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed) Steroid,Catatoxic Steroids,Steroids, Catatoxic

Related Publications

Kavitha Avadhani, and Padmamalini Mahendradas, and Rohit Shetty, and Bhujang K Shetty
January 1979, Transactions of the ophthalmological societies of the United Kingdom,
Kavitha Avadhani, and Padmamalini Mahendradas, and Rohit Shetty, and Bhujang K Shetty
May 2017, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics,
Kavitha Avadhani, and Padmamalini Mahendradas, and Rohit Shetty, and Bhujang K Shetty
January 2018, Ocular immunology and inflammation,
Kavitha Avadhani, and Padmamalini Mahendradas, and Rohit Shetty, and Bhujang K Shetty
January 2017, Current drug safety,
Kavitha Avadhani, and Padmamalini Mahendradas, and Rohit Shetty, and Bhujang K Shetty
January 2016, Ocular immunology and inflammation,
Kavitha Avadhani, and Padmamalini Mahendradas, and Rohit Shetty, and Bhujang K Shetty
December 2004, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics,
Kavitha Avadhani, and Padmamalini Mahendradas, and Rohit Shetty, and Bhujang K Shetty
July 2003, Eye (London, England),
Kavitha Avadhani, and Padmamalini Mahendradas, and Rohit Shetty, and Bhujang K Shetty
March 2016, The British journal of ophthalmology,
Kavitha Avadhani, and Padmamalini Mahendradas, and Rohit Shetty, and Bhujang K Shetty
December 2004, Journal francais d'ophtalmologie,
Kavitha Avadhani, and Padmamalini Mahendradas, and Rohit Shetty, and Bhujang K Shetty
May 1980, Clinical toxicology,
Copied contents to your clipboard!